Robust scale-down agitation models simulate mechanical stress essential for assessing and preventing protein aggregation in ...

At AAPS PharmSci 360 2025, held from Nov. 9–12 in San Antonio, Texas, Corey Bloom, PhD, associate director, CMC (chemistry, ...

The FDA's CNPV program accelerates product reviews to two months for national priority products, enhancing market entry speed ...

To prevent catastrophic loss of expertise and investment, government and academic leaders say coordinated policy and significant investment in workforce talent are urgently needed in the UK.

To learn more about how method validation is performed for biomarker bioanalysis, Pharmaceutical Technology ® spoke with ...

A streamlined workflow using Six Sigma's DMAIC methodology was developed to identify and mitigate visible particles in ...

Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...

A worldwide, exclusive license is being granted to develop and commercialize enzyme replacement therapies using proprietary platform technology.

Thermo Fisher’s Jennifer Cannon reviews the first year of the company’s Accelerator Drug Development suite of services and ...

At AAPS PharmSci 360 2025, Elly Zhou says digital twins helped forecast the effects of drugs on human drugs via a digital control arm.

Editor's note: this interview was originally published on BioPharmInternational.com.

Steve will be monitoring the Rapid Fires: AI/ML in Bioanalysis session on Monday, Nov. 10, 2025 at 3PM CT at AAPS PharmSci ...